???global.info.a_carregar???
D Ferreira is a cancer researcher and member of the Portuguese Society of Human Genetics (Sociedade Portuguesa de Genética Humana - SPGH), with a keen interest in the application of new technologies to healthcare and biological sciences and in multidisciplinary R&D projects. Throughout his career, D Ferreira has participated in 11 research projects and counts 2+ years of international experience. After a brief stint in the neurosciences field, he has focused his efforts in the study of several cancers, with a particular focus in cancers of the digestive system. D Ferreira has a degree in Biochemistry by the University of Porto and a master degree in Biology, where he has studied multiple aspects of Hodgkin´s lymphoma. D Ferreira concluded recently a PhD degree in Molecular and Cellular Biotechnology Applied to Health Sciences (BiotechHealth). Throughout his PhD studies, D Ferreira, specialized in biotechnology, materials science and tissue engineering, with a particular focus in the development of organ-on-a-chip platforms, a work that generated several first-author publications, as well as a patent. In 2016, D Ferreira concluded successfully a post-graduation in Intelectual Property by the World Intelectual Property Organization (WIPO). D Ferreira has published 11 peer reviewed articles in international journals, as well as 4 abstracts in conference proceedings, a book chapter and a patent on a microfabrication technique, for complex multilayered organ-on-a-chip devices with integrated microactuators. D Ferreira has an h-index of 10, having been cited 209 times (source: Scopus - Author ID 55927177600) and has presented his work multiple times in international and national conferences through poster and oral presentations. D Ferreira currently holds a post-doc researcher position at i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Associação where he is the principal investigator of 2 research projects, having secured over 80.000 euros of funding, in his first year as a post-doc. Since then he has gained a further 136.000 euros divided by 3 complementary projects which will fund his research until the end of 2026. D Ferreira was distinguished at the 12th International Meeting of the Portuguese Society for Stem Cells and Cellular Therapy with a best oral communication award and also with the International 3Rs prize awarded by the National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs, UK). Recently we won the 2023 European Society of Human Genetics Fellowship of Excellence and the Best Clinical Research Award at the 27th Annual SPGH conference. His patented technology was also an honorable mention at the 2022 Lush Prize awards (finalist for the Science Category) and top 3 finalist at the 2022 Altice International Innovation Awards. In 2023 he was an honorable mention for the Alfredo da Silva Awards in the Sustainability in Health Category, His awards also include a prestigious short-term EMBO fellowship. International recognition has garnered D Ferreira several invitations to teach at Advanced Course Units in several Portuguese Universities, as well as speaker invitations at international meetings and an invitation to join the scientific commitee for the PhDay Conference at i3S and was a member of the organizing committee of the 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting held in June 2024, Porto, Portugal. International recognition has earned D Ferreira an invitation to participate in the preparation and submission of a COST Action on Advanced Microfluidics for Applied Diagnostics in 2022 and integrated a Twinning- Bottom Up application in 2023. D Ferreira is an invited reviewer for the journals, Bioprinting, Organoids and Cancers. D Ferreira has supported and supervised several traineeship and master students. D Ferreira is a member of the team that created and manages the first Portuguese 3Rs Knowledge Center and i3S' Startup Hub.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Daniel André Gonçalves Ferreira

Nomes de citação

  • Ferreira, Daniel A.

Identificadores de autor

Ciência ID
D61E-C674-D0F4
ORCID iD
0000-0002-9712-1460
Researcher Id
AAK-4154-2020
Scopus Author Id
55927177600

Endereços de correio eletrónico

  • daniel.ferreira@i3s.up.pt (Profissional)

Telefones

Telefone
  • (00351) 226 074 90 (Profissional)

Moradas

  • R. Alfredo Allen 208, 4200-135, Porto, Porto, Portugal (Profissional)

Websites

Domínios de atuação

  • Ciências Naturais - Ciências Biológicas - Bioquímica
  • Ciências Médicas e da Saúde - Biotecnologia Médica - Biotecnologia Aplicada à Saúde
  • Ciências Naturais - Ciências Biológicas - Biologia Molecular
  • Ciências Médicas e da Saúde - Biotecnologia Médica - Tecnologias que envolvem a Manipulação de Células,Tecidos,Órgãos ou todo o Organismo

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Espanhol; Castelhano Utilizador independente (B1) Utilizador proficiente (C1) Utilizador independente (B1) Utilizador proficiente (C2) Utilizador independente (B1)
Formação
Grau Classificação
2021/12/14
Concluído
 International Doctoral Programme in Molecular and Cellular Biotechnology Applied to Health Sciences (Doutoramento)
Especialização em Microfluídics and organ-on-a-chip platforms. Genetics of Cancer, Gastric Cancer
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"A tissue engineering approach to fabricate a stomach-on-a-chip: a biomimetic device to decode the role of CD44v6 in gastric cancer" (TESE/DISSERTAÇÃO)
 Aprovado por unanimidade
2016/10 - 2016/11
Concluído
 General Course on Intellectual Property (Pós-Graduação)
Especialização em Intelectual Property
World Intelectual Property Organization, Suiça
2009/12/22
Concluído
 Biology (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
"Optimization of cell cycle synchronization and transfection protocols in a Hodgkin's Lymphoma derived human cell line." (TESE/DISSERTAÇÃO)
 17
2004/11/29
Concluído
 Biochemistry (Licenciatura)
Especialização em Bioquímica Aplicada
Universidade do Porto Faculdade de Ciências, Portugal
"Role and regulation of phosphoERKs activity in vesical function under different conditions." (TESE/DISSERTAÇÃO)
 13
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2022 - Atual Pós-doutorado (Investigação) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2012 - 2021 Investigador (Investigação) Instituto Nacional de Engenharia Biomédica, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal
2017/09/15 - 2018/03/31 Investigador visitante (Investigação) Instituto Nacional de Engenharia Biomédica, Portugal
Technische Universität Wien Fakultät für Technische Chemie, Áustria
2016 - 2016 Investigador visitante (Investigação) Instituto Nacional de Engenharia Biomédica, Portugal
INESC Microsistemas e Nanotecnologias, Portugal
2015 - 2015 Investigador visitante (Investigação) Instituto Nacional de Engenharia Biomédica, Portugal
INESC Microsistemas e Nanotecnologias, Portugal
2008 - 2012 Investigador (Investigação) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2011/01/01 - 2011/04/30 Investigador visitante (Investigação) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
VU Medisch Centrum, Países Baixos
2006 - 2008 Investigador (Investigação) Leids Universitair Medisch Centrum, Países Baixos
Leids Universitair Medisch Centrum, Países Baixos
2005 - 2006 Investigador (Investigação) Instituto Gulbenkian de Ciência, Portugal
Instituto Gulbenkian de Ciência, Portugal
Projetos

Bolsa

Designação Financiadores
2014 - 2021 A tissue engineering approach to fabricate a stomach-on-a-chip: a biomimetic device to decode the role of CD44v6 in gastric cancer
PD/BD/105976/2014
Bolseiro de Doutoramento
Instituto Nacional de Engenharia Biomédica, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2013 - 2014 TUMORTAG - Tumor-targeted nanoparticles for early diagnosis of gastric cancer
PTDC/CTM-NAN/120958/2010
Bolseiro de Investigação
Fundação para a Ciência e a Tecnologia
Concluído
2011 - 2013 Exploring the role of E-Cadherin-HER interaction in the search of molecular biomarkers for the clinical management of gastric cancer patients
PIC/IC/82923/2007
Outra
VU Medisch Centrum, Países Baixos
Concluído
2011/01 - 2011/03 Systematic analysis of novel and previously characterized E-cadherin expression repressors/modulators in gastric cancer
ASTF number 466-2010
Investigador
Amsterdam UMC Locatie VUmc Instituut voor onderwijs en opleiden, Países Baixos
 European Molecular Biology Organization (EMBO)
2009 - 2011 Role of novel regulatory mechanisms in the loss of E-cadherin expression
PTDC/SAU-GMG/72168/2006
Bolseiro de Mestrado
Fundação para a Ciência e a Tecnologia
Concluído
2006 - 2008 Prevention, detection and molecular characterisation of mismatch repair-related hereditary cancers of the digestive system
FP6-018754
Bolseiro de Investigação
Leids Universitair Medisch Centrum, Países Baixos
 European Commission Sixth Framework Programme
Concluído
2005 - 2006 Study of the function of A Kinase Anchoring Proteins (AKAPs) on the regulation of synaptic activity
POCTI/BIA-BCM/56938/2004
Bolseiro de Investigação
Associação para a Inovação e Desenvolvimento da FCT
Concluído

Projeto

Designação Financiadores
2024/12/31 - Atual Concurso NCH-PT 2024 | Projeto HDCHIP (N. Ref. NCH2024005)
NCH2024005
Investigador responsável
2024/12/01 - Atual Caixa Impulse Innovation 2024 - Stage 1 Project
CI24-10293
Investigador responsável
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2023/01 - Atual Disclosing the genesis of hereditary stomach cancer through organ-on-a-chip technology
2022.02951.PTDC
Investigador responsável
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 Fundação para a Ciência e a Tecnologia
Em curso
2023 - Atual PREVENTABLE - Sustainable care for rare tumor risk syndromes
Project number 101095483
Investigador Pós-doutorado
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Em curso
2023/01 - 2023/12 3Rs international Prize Award - £28000 total funding
N/A
Investigador responsável
National Centre for the Replacement Refinement and Reduction of Animals in Research
Em curso
2021 - 2023 Life-time Risk Estimations and Genetic Modifiers Of Hereditary Diffuse Gastric Cancer (LEGOH)
PTDC/BTM-TEC/6706/2020
Investigador Pós-doutorado
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 Fundação para a Ciência e a Tecnologia
Em curso
Produções

Publicações

Artigo em conferência
  1. Daniel A. Ferreira; João P. Conde; Peter Ertl; Carla Oliveira; Pedro L. Granja. "Proceedings of the 25th Annual Meeting of the Portuguese Society of Human Genetics (SPGH – Sociedade Portuguesa de Genética Humana)". 2021.
    10.1097/md.0000000000029313
Artigo em revista
  1. Daniel A. Ferreira; João P. Conde; Mario Rothbauer; Peter Ertl; Pedro L. Granja; Carla Oliveira. "Bioinspired human stomach-on-a-chip with in vivo like function and architecture". Lab on a Chip (2023): https://doi.org/10.1039/D2LC01132H.
    10.1039/D2LC01132H
  2. Mafalda Santos; Marta Ferreira; Patrícia Oliveira; Nuno Mendes; Ana André; André F. Vieira; Joana B. Nunes; et al. "Epithelial-Mesenchymal Plasticity Induced by Discontinuous Exposure to TGFß1 Promotes Tumour Growth". Biology (2022): https://www.mdpi.com/2079-7737/11/7/1046.
    10.3390/biology11071046
  3. Daniel A. Ferreira; Mario Rothbauer; João P. Conde; Peter Ertl; Carla Oliveira; Pedro L. Granja. "A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators". Advanced Science (2021): https://doi.org/10.1002/advs.202003273.
    10.1002/advs.202003273
  4. Ferreira, Daniel. "Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells". Cancers (2020): http://dx.doi.org/10.3390/cancers12040858.
    10.3390/cancers12040858
  5. Ferreira, Daniel. "Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles". European Journal of Pharmaceutics and Biopharmaceutics 127 (2018): 366-370. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043984392&doi=10.1016%2fj.ejpb.2018.03.005&partnerID=40&md5=16637db821f292c61e9e4a81024ad38a.
    10.1016/j.ejpb.2018.03.005
  6. Ferreira, Daniel. "Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6". Acta Biomaterialia 81 (2018): 208-218. http://www.sciencedirect.com/science/article/pii/S1742706118305725.
    https://doi.org/10.1016/j.actbio.2018.09.043
  7. Bianca N. Lourenço; Nora L. Springer; Daniel Ferreira; Carla Oliveira; Pedro L. Granja; Claudia Fischbach. "CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling". Integrative Biology 10 3 (2018): 145-158. https://doi.org/10.1039/C7IB00179G.
    10.1039/C7IB00179G
  8. Oliveira, Patricia; Carvalho, Joana; Rocha, Sara; Azevedo, Mafalda; Vieira, Andre F.; Ferreira, Daniel; Mendes, Nuno; et al. "Epithelial-mesenchymal-epithelial transition induced by long term exposure to TGFB1 creates cellular heterogeneity". Cancer Research (2016): https://publons.com/publon/7147057/.
    10.1158/1538-7445.AM2016-1611
  9. Bordeira-Carriço, R.; Ferreira, D.; Mateus, D.D.; Pinheiro, H.; Pêgo, A.P.; Santos, M.A.S.; Oliveira, C.. "Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA". European Journal of Human Genetics 22 9 (2014): 1085-1092. http://www.scopus.com/inward/record.url?eid=2-s2.0-84906269658&partnerID=MN8TOARS.
    10.1038/ejhg.2013.292
  10. Drost, M.; Lützen, A.; Van Hees, S.; Ferreira, D.; Calléja, F.; Zonneveld, J.B.M.; Nielsen, F.C.; Rasmussen, L.J.; De Wind, N.. "Genetic screens to identify pathogenic gene variants in the common cancer predisposition Lynch syndrome". Proceedings of the National Academy of Sciences of the United States of America 110 23 (2013): 9403-9408. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878715707&partnerID=MN8TOARS.
    10.1073/pnas.1220537110
  11. Pinheiro, H.; Carvalho, J.; Oliveira, P.; Ferreira, D.; Pinto, M.T.; Osoquot;rio, H.; Licastro, D.; et al. "Transcription initiation arising from E-cadherin/CDH1 intron2: A novel protein isoform that increases gastric cancer cell invasion and angiogenesis". Human Molecular Genetics 21 19 (2012): 4253-4269. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866408689&partnerID=MN8TOARS.
    10.1093/hmg/dds248
  12. Cruz, C.D.; Ferreira, D.; Mcmahon, S.B.; Cruz, F.. "The activation of the ERK pathway contributes to the spinal c-fos expression observed after noxious bladder stimulation". Somatosensory and Motor Research 24 1-2 (2007): 15-20. http://www.scopus.com/inward/record.url?eid=2-s2.0-34547865090&partnerID=MN8TOARS.
    10.1080/08990220601143265
  13. Cruz, CD; Ferreira, D; McMahon, SB; Cruz, F. "Phosphorylation of extracellular signal regulated kinases (ERK) in the spinal cord depends on vanilloid-insensitive primary afferents as shown by intravesical instillation of resiniferatoxin". The FEBS Journal (2005): https://publons.com/publon/28317163/.
Capítulo de livro
  1. Tiago dos Santos; Ferreira, Daniel A.; Pedro L. Granja. "Chapter3.2 - Cell-based in vitro models for gastric permeability studies". In Concepts and models for drug permeability studies. Woodhead Publishing, 2023.
    Publicado
Poster em conferência
  1. Ferreira, Daniel A.. "A novel biomimetic tool to study disease initiation of deadly Hereditary Diffuse Gastric Cancer syndrome". Trabalho apresentado em PREVENTABLE Mid-Term Conference, 2024.
  2. Daniel A. Ferreira. "A novel biomimetic tool to study disease initiation of deadly Hereditary Diffuse Gastric Cancer syndrome". Trabalho apresentado em IV INTERNATIONAL MEETING OF THE PORTUGUESE SOCIETY OF GENETICS, 2023.
  3. Ferreira, Daniel. "A bioinspired human stomach-on-a-chip to study gastric cancer initiation". Trabalho apresentado em 28th Porto Cancer Meeting, 2022.
  4. Ferreira, Daniel. "Fabrication of a human stomach-on-a-chip device displaying organ-like features". Trabalho apresentado em 25th Annual Meeting of the SPGH, 2021.
  5. Ferreira, Daniel. "A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators". Trabalho apresentado em 31st Conference of the European Society for Biomaterials (ESB2021) together with 43rd Annual Congress of the Iberian Society of Biomechanics and Biomaterials (SIBB), 2021.
  6. Ferreira, Daniel. "CD44v6 in gastric cancer, a marker of progression or a culprit?". Trabalho apresentado em 5th Advanced Summer School: Interrogations at the Biointerface – the nano/medicine interface, 2016.
Resumo em conferência
  1. Ferreira, Daniel. "PO-501 Deconstructing the role of cd44 in gastric cancer resistance to cisplatin". 2018.
    10.1136/esmoopen-2018-eacr25.518
  2. Ferreira, Daniel. "Abstract 1611: Epithelial-mesenchymal-epithelial transition induced by long term exposure to TGFB1 creates cellular heterogeneity". 2016.
    10.1158/1538-7445.am2016-1611

Propriedade Intelectual

Patente
  1. Ferreira, Daniel. 2022. "Fabrication of microactuator and in-line degasser in organ-on-a-chip devices and methods thereof".
    Concedida/Emitida

Outros

Outra produção
  1. CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients. 2018. Carla Pereira; Daniel Ferreira; Carolina Lemos; Diana Martins; Nuno Mendes; Daniela Almeida; Pedro Granja; et al. https://doi.org/10.1101/468934.
    10.1101/468934
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2024/06/15 A novel model for early cancer detection in Hereditary Diffuse Gastric Cancer 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting
i3S - Instituto de Investigação e Inovação em Saúde (Porto, Portugal)
2024/06/14 In vitro, in vivo and in silico models of HDGC 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting
i3S - Instituto de Investigação e Inovação em Saúde (Portugal)
2023/11 AN INSIGHT ON THE ORIGINS OF HEREDITARY DIFFUSE GASTRIC CANCER THROUGH ORGANOID DRIVEN ORGAN-ON-A-CHIP TECHNOLOGY 27th Annual SPGH Meeting, Lisbon, Portugal
(Lisbon, Portugal)
2023/04 Chipping away at animal models - Novel fabrication methodology for organ-on-a-chip devices, towards better personalized medicine and reducing impact on animal based research Remodel Conference
i3S - Instituto de Investigação e Inovação em Saúde - Universidade do Porto (Porto, Portugal)
2023 HDGC-on-a-chip. Merging patient-derived iPSCs and microfluidics to disclose the genesis of Hereditary Diffuse Gastric Cancer i3S Post-doc Seminars
i3S - Instituto de Investigação e Inovação em Saúde - Universidade do Porto
2023 Merging patient-derived iPSCs and organ-on-a-chip technology to disclose the genesis of Hereditary Diffuse Gastric Cancer 2023 European Society of Human Genetics Conference
European Society of Human Genetics (Glasgow, Reino Unido)
2022/10 Open access organ-on-a-chip technology for life-sciences PIPE-CF & UK CF Infection Biorepository Joint workshop
PIPE-CF & UK CF (Liverpool, Reino Unido)
2022/03 Human stomach-on-a-chip device displaying organ-like features 12th International Meeting of the SPCE-TC
2022 Bioinspired human stomach-on-chip with in-vivo like function and architecture i3S Post-doc Seminars
i3S - Instituto de Investigação e Inovação em Saúde - Universidade do Porto (Portugal)
2022 A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators International 3Rs prize award event
(Reino Unido)
2021/05 Órgão-em-chip como alternativa à experimentação animal VI Jornadas de Bioquímica - "O Passaporte para a Inovação"
Faculdade de Ciências da Universidade do Porto (Portugal)
2016 CD44v6 in gastric cancer, a marker of progression or a culprit? 5th Advanced Summer School: Interrogations at the Biointerface – the nano/medicine interface
Instituto Nacional de Engenharia (Porto, Portugal)
2012 Systematic analysis of novel and previously characterized E-cadherin expression repressors/modulators in gastric cancer Third I3S Scientific Retreat
(Póvoa do Varzim, Portugal)

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2024/09 - Atual Early detection of Diffuse Gastric Cancer in Hereditary Diffuse Gastric Cancer
Orientador
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2024 - 2024 Development of an organ-on-a-chip platform to study Hereditary Diffuse Gastric Cancer syndrome
Orientador
 PROJETO INTEGRADOR EM BIOENGENHARIA MOLECULAR (Licenciatura/Bacharelato)
Universidade do Porto Faculdade de Engenharia, Portugal
2023 - 2024 A biomarker-based model for early cancer detection in Hereditary Diffuse Gastric Cancer
Orientador
 Biologia Celular e Molecular (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
2022/09 - 2023/07 Development of an in-vitro biomimetic model of HDGC
Orientador
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2024/10 - Atual 3R Day - Models in Biomedical Research Conference (2024)
Conferência (Membro da Comissão Organizadora)
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2024/06 - Atual 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting (2024/06)
Conferência (Membro da Comissão Organizadora)
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2016 - Atual Organizer of PenguinCon, a social event conference aimed at boardgames and miniatures games enthusiasts. (2016)
Festival (Presidente da Comissão Organizadora)
2015 - Atual Member of the organizing comittee for the 2nd Annual Biotechhealth Symposium - Biotechnology Towards Medicine. (2015)
Conferência (Membro da Comissão Organizadora)

Júri de grau académico

Tema
Tipo de participação 		Nome do candidato (Tipo de grau)
Instituição / Organização
2024/05/09 Advanced microfluidic devices for cell culture and point-of-care immunoassays
Arguente principal
 Pedro Gabriel Condelipes Monteiro (Doutoramento)
Universidade de Lisboa Instituto Superior Técnico, Portugal

Arbitragem científica em conferência

Nome da conferência Local da conferência
2022 - 2022 PhDay: Building Paths: The science behind us i3S - Instituto de Investigação e Inovação em Saúde - Universidade do Porto

Consultoria / Parecer

Descrição da atividade Instituição / Organização
2018 - 2018 Invited evaluator at the Agência de Avaliação e Acreditação do Ensino Superior (A3ES). Served as an evaluator in the process of accrediation of higher degree courses (Scientific area of Biological Sciences) in 2018.
2016 - 2016 Invited evaluator at the Agência de Avaliação e Acreditação do Ensino Superior (A3ES). Served as an evaluator in the process of accrediation of higher degree courses (Scientific area of Biological Sciences) in 2016.

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2023/05 - Atual Background, genetics and pathology of gastric cancer (Doutoramento)
2023 - Atual Advanced Cell culture techniques: from basic cell biology to Bioengineering (Doutoramento) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2023/03 - 2023/03 Modeling the gastric environment - From 2D to advanced 3D models Advanced In Vitro modeling approaches (Pós-Graduação) Universidade do Minho Escola de Ciências da Saúde, Portugal
2019 - 2019 Tackling the gastric barrier: concepts, models and challenges In vitro models of biological barriers for Health Sciences Applications (Doutoramento) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Universidade do Porto Faculdade de Farmácia, Portugal

Entrevista (jornal / revista)

Descrição da atividade Jornal / Forum
2023 Editor's Choice: «Alternative to soft lithography for the production of elastomer-based organ-on-chip devices with micro-actuators», by Daniel Ferreira, Carla Oliveira and Pedro Granja i3S Newsletter - Editor's choice column
2023 SPGH premeia investigação do i3S em Cancro Gástrico Difuso Hereditário
2023 SPGH awards Best Clinical Research Work to i3S project on Hereditary DIffuse Gastric Cancer
2022 Técnica alternativa à experimentação animal vale prémio internacional ao i3S https://shorturl.at/otvI9 Notícias U Porto
2022 Investigador do i3S premiado por produzir um estômago-em-chip Notícias U Porto
2022 Sampedrense premiado por desenvolver um estômago-em-chip Vivacidade
2021 Interview for national Magazine, Visão - Nova técnica permite criar em pouco tempo e baixo custo um órgão-em-chip Visão
2021 Nova tecnologia desenvolvida em parceria com investigadores do iST e da TU Wien permite fabricar um órgão-em-chip em poucas horas Notícias U Porto
2021 Investigadores do Porto criam técnica alternativa à experimentação em animais Website - Porto's City Hall
2021 Cientistas portugueses encontram alternativas para substituir experimentação animal WELECTRIC - Portuguese technology news outlet

Membro de associação

Nome da associação Tipo de participação
2021 - Atual Portuguese Society of Human Genetics (Sociedade Portuguesa de Genética Humana - SPGH)

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2023/04 - Atual Committee member involved in the creation and management of the first 3R Knowledge Center in Portugal. This infrasctucture is a centralized knowledge hub for the 3Rs principles in animal research (replacement, reduction and refinement) - https://3rknowledge.i3s.up.pt/
Membro
 Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Distinções

Prémio

2024 Prémio FAZ Ciência 2024 - Honorable Mention - Top 3
2023 European Society of Human Genetics Fellowship of Excellence
European Society of Human Genetics, Áustria
2023 Best Clinical Research Award - 27th Annual SPGH Conference, Lisbon, Portugal
Sociedade Portuguesa de Genética Humana, Portugal
2023 Honorable Mention at the 2023 Alfredo da Silva Awards - Sustainability in Science Category
2022 Best oral presentation - 12th International Meeting of the Portuguese Society for Stem Cells and Cell therapies
Sociedade Portuguesa de Células Estaminais e Terapia Celular, Portugal
2022 International 3Rs prize
National Centre for the Replacement Refinement and Reduction of Animals in Research, Reino Unido
2022 Finalist (top 3) - Altice International Innovation Awards 2022 - PhD thesis category
Altice Labs, Portugal
2022 Finalist in the Science Category - Lush Prize 2022 - Science Category
Flushing Area Library, Estados Unidos
2011 EMBO short term Fellowship Award
European Molecular Biology Organization (EMBO), Alemanha